Heena Tabassum1, Mohammad Waseem2, Suhel Parvez3, M Irfan Qureshi1. 1. Proteomics and Bioinformatics Laboratory, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India. 2. Department of Medical Elementology and Toxicology, Jamia Hamdard (Hamdard University), New Delhi, India. 3. Department of Medical Elementology and Toxicology, Jamia Hamdard (Hamdard University), New Delhi, India. Electronic address: sparvez@jamiahamdard.ac.in.
Abstract
BACKGROUND AND AIMS: Oxaliplatin is a widely employed platinum-derived chemotherapeutic agent commonly used for the treatment of colorectal cancer. Unfortunately, the benefit of this important drug is compromised by severe side effects such as neuropathy, ototoxicity, gastrointestinal toxicity, and hematological toxicity. Recently, few studies have also suggested the occurrence of hepatotoxicity in oxaliplatin-treated patients. Mitochondria have emerged as targets for anticancer drugs in various kinds of toxicity including hepatotoxicity that can lead to neoplastic disease. Oxidative stress is a well-established biomarker of mitochondrial toxicity. The purpose of this study was to investigate the dose-dependent damage caused by oxaliplatin on isolated liver mitochondria under in vitro conditions. METHODS: The study was conducted in mitochondria isolated from liver of Wistar rats. Oxaliplatin was incubated with mitochondria in a dose-dependent manner under in vitro conditions. Oxidative stress indexes, non-enzymatic and enzymatic antioxidants were evaluated, looking at the overall armamentarium against the toxicity induced by oxaliplatin. RESULTS: Oxaliplatin caused a significant rise in the mitochondrial oxidative stress indexes lipid peroxidation and protein carbonyl. Alterations in the levels of non-enzymatic antioxidants and activities of enzymatic antioxidants were also observed. CONCLUSION: Oxidative stress plays an important role in the mitochondrial toxicity of oxaliplatin. The integrity of the hepatic tissue is compromised by the reactive oxygen species-mediated lipid peroxidation and protein carbonyl formation.
BACKGROUND AND AIMS: Oxaliplatin is a widely employed platinum-derived chemotherapeutic agent commonly used for the treatment of colorectal cancer. Unfortunately, the benefit of this important drug is compromised by severe side effects such as neuropathy, ototoxicity, gastrointestinal toxicity, and hematological toxicity. Recently, few studies have also suggested the occurrence of hepatotoxicity in oxaliplatin-treated patients. Mitochondria have emerged as targets for anticancer drugs in various kinds of toxicity including hepatotoxicity that can lead to neoplastic disease. Oxidative stress is a well-established biomarker of mitochondrial toxicity. The purpose of this study was to investigate the dose-dependent damage caused by oxaliplatin on isolated liver mitochondria under in vitro conditions. METHODS: The study was conducted in mitochondria isolated from liver of Wistar rats. Oxaliplatin was incubated with mitochondria in a dose-dependent manner under in vitro conditions. Oxidative stress indexes, non-enzymatic and enzymatic antioxidants were evaluated, looking at the overall armamentarium against the toxicity induced by oxaliplatin. RESULTS:Oxaliplatin caused a significant rise in the mitochondrial oxidative stress indexes lipid peroxidation and protein carbonyl. Alterations in the levels of non-enzymatic antioxidants and activities of enzymatic antioxidants were also observed. CONCLUSION: Oxidative stress plays an important role in the mitochondrial toxicity of oxaliplatin. The integrity of the hepatic tissue is compromised by the reactive oxygen species-mediated lipid peroxidation and protein carbonyl formation.
Authors: James C Sorensen; Aaron C Petersen; Cara A Timpani; Dean G Campelj; Jordan Cook; Adam J Trewin; Vanesa Stojanovska; Mathew Stewart; Alan Hayes; Emma Rybalka Journal: Front Pharmacol Date: 2017-04-10 Impact factor: 5.810
Authors: Tamara E Lacourt; Elisabeth G Vichaya; Gabriel S Chiu; Robert Dantzer; Cobi J Heijnen Journal: Front Behav Neurosci Date: 2018-04-26 Impact factor: 3.558
Authors: Abdullah F AlAsmari; Metab Alharbi; Faleh Alqahtani; Fawaz Alasmari; Mohammed AlSwayyed; Sami I Alzarea; Ibrahim A Al-Alallah; Adel Alghamdi; Hassan M Hakami; Meshal K Alyousef; Youssef Sari; Nemat Ali Journal: Antioxidants (Basel) Date: 2021-12-15